financetom
Business
financetom
/
Business
/
Citi Trends Down After Q1 Results - Here's Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Citi Trends Down After Q1 Results - Here's Why
Jun 4, 2024 5:38 AM

Citi Trends, Inc. ( CTRN ) shares are trading lower in the premarket session on Tuesday after reporting mixed first-quarter results and revised full year 2024 outlook.

The company reported quarterly sales of $186.3 million, which increased by 3.7% year over year. However, sales missed the Wall Street view of $187.37 million.

Citi Trends ( CTRN ) closed three stores and remodeled 20 stores to end the quarter with 599 locations.

“We are mindful of the challenging economic environment for the lower-income consumer,” said Interim Chief Executive Officer Ken Seipel.

The company registered comparable sales growth of 3.1%, with gross margin at 38.7%. “The quarter was further highlighted by gross margin expansion of 160 basis points compared to last year,” Seipel said. 

Citi Trends ( CTRN ) reported an adjusted EBITDA loss of $0.8 million, narrower than an adjusted loss of $3.2 million in the year-ago period.

Citi Trends ( CTRN ) had cash of $58.2 million at quarter-end, with no debt and no borrowings under a $75 million credit facility.

“Our balance sheet has ample liquidity and no debt because of our financial disciplines, which in turn allows us the flexibility to fund business opportunities with acceptable rates of returns,” Seipel added. 

Citi Trends ( CTRN ) reported an adjusted loss per share of 32 cents, better than the consensus loss of 35 cents.

Last week, the specialty value retailer disclosed that David Makuen has stepped down as CEO and a member of the Board. The Board said it will consider external candidates, as well as Seipel, in the CEO search.

Outlook Lowered: Citi Trends ( CTRN ) lowered its FY24 comparable store sales outlook. The company projects growth of low to mid-single digits (prior view: growth of mid-single digits) and sees gross margin expansion of 75-100 basis points, consistent with previous outlook.

The company continues to see full-year EBITDA in the range of $4 million to $10 million.

“We will execute the business initiatives within our control that will position us to achieve our EBITDA target for the year,” Seipel said.

Price Action: CTRN shares are trading lower by 3.65% at $23.75 premarket at last check Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved